Comparison of Hemospray~? and Endoclot? for the treatment of gastrointestinal bleeding

查看全文 作　　者：Francesco [1]Vitali;Andreas [1]Naegel;Raja [1]Atreya;Steffen [1]Zopf;Clemens [1]Neufert;Juergen [1]Siebler;Markus F [1]Neurath;Timo [1]Rath

机构地区：[1]Ludwig Demling Endoscopy Center of Excellence, Division of Gastroenterology, Friedrich-Alexander-University

出　　处：《World Journal of Gastroenterology》索引2019年第25卷第13期,共11页

摘　　要：BACKGROUND Gastrointestinal(GI) bleeding is a common indication for endoscopy. For refractory cases, hemostatic powders(HP) represent 'touch-free' agents.AIM To analyze short term(ST-within 72 h-) and long-term(LT-within 30 d-) success for achieving hemostasis with HP and to directly compare the two agents Hemospray(HS) and Endoclot(EC).METHODS HP was applied in 154 consecutive patients(mean age 67 years) with GI bleeding.Patients were followed up for 1 mo(mean follow-up: 3.2 mo).RESULTS Majority of applications were in upper GI tract(89%) with following bleeding sources: peptic ulcer disease(35%), esophageal varices(7%), tumor bleeding(11.7%), reflux esophagitis(8.7%), diffuse bleeding and erosions(15.3%). Overall ST success was achieved in 125 patients(81%) and LT success in 81 patients(67%). Re-bleeding occurred in 27% of all patients. In 72 patients(47%), HP was applied as a salvage hemostatic therapy, here ST and LT success were 81% and64%, with re-bleeding in 32%. As a primary hemostatic therapy, ST and LT success were 82% and 69%, with re-bleeding occurring in 22%. HS was more frequently applied for upper GI bleeding(P = 0.04)CONCLUSION Both HP allow for effective hemostasis with no differences in ST, LT success and re-bleeding. 关键词：Hemostatic POWDER GASTROINTESTINAL BLEEDING Hemospray Endoclot HAEMOSTASIS

相关文献

参考文献（27）
引证文献（3）
耦合文献（0）

参考文献(27)

引证文献(3)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Comparison of Hemospray~? and Endoclot? for the treatment of gastrointestinal bleeding

参考文献(27)

引证文献(3)

用户提示